Compare ARK Genomic Revolution ETF (ARKG) vs Bit Digital Inc (BTBT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Bit Digital Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Bit Digital Inc trades at $1.66 (market cap $599.01M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Bit Digital Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | BTBT | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $4.22 |
52-Week Low | $23.09 | $1.27 |
Market Cap | — | $599.01M |
Enterprise Value | — | $888.32M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BTBT trades at $1.69, showing slight positive momentum with a 0.6% daily gain, but faces a bearish technical outlook with 15 sell signals versus 3 buys. The company reported a net loss of $80.32 million in 2025, with revenue of $113.56 million, and has missed earnings expectations for three consecutive quarters. Recent strategic moves include a $100 million loan facility for WhiteFiber and a $20 million Ethereum purchase to bolster its asset position.
The outlook remains challenging due to persistent losses and negative profit margins, though analyst consensus is unanimously bullish with 2 buy ratings. Key risks include execution challenges in AI infrastructure investments, reliance on financing for cash flow, and sensitivity to cryptocurrency market volatility impacting its strategic asset holdings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Bit Digital Inc
Bit Digital is a sustainability-focused digital asset production company. It primarily engages in Bitcoin mining and Ethereum staking while also providing high-performance computing (HPC) infrastructure for AI applications.
Read more on BTBT →
